-->
Search the ArchivesNavigationContact InformationThe Citizen Newspapers For Advertising Information Email us your news! For technical difficulties |
Stem cell debate distorted by big media, speaker arguesTue, 06/12/2007 - 5:15pm
By: Kevin Wandra
Those who are living with debilitating diseases and injuries are desperately seeking cures. Embryonic stem cell research could provide the cures they are searching for, many scientists, physicians and politicians say. Josh Brahm says there is a better, and more morally and ethically sound, solution: adult stem cell research. Brahm, director of education and public relations for Georgia Right to Life, spoke at a stem cell research seminar hosted by Coweta-Fayette Right to Life on Thursday at the Fayette County Public Library. He started his presentation by explaining the importance of stem cells and stem cell research. “Stem cells are the building blocks of life,” Brahm said. “When you were first conceived, your body was entirely made up of stem cells. So what is stem cell research? Put simply, stem cell research is based on the idea that if you can make new, healthy cells for a part of the body that is unhealthy, or broken, they [physicians] may be able to repair it.” Backed by a video presentation, Brahm went on to discuss, in detail, the debate regarding stem cell research, including the significant differences between the two most common types of stem cell research, embryonic and adult. Embryonic stem cells are taken from three sources: aborted fetal tissue, cloned human embryos and leftovers from in-vitro fertilization. Adult stem cells can be extracted from a host of sources, none of which involves the destruction of a human embryo: umbilical cord blood, placental cells, amniotic fluid, bone marrow, fat obtained from liposuction, skeletal muscle and the epidermis, among many others. The biggest difference between the two types of stem cells is that embryonic stem cells are pluripotent, which means they can become all cell types of the body. Adult stem cells are more limited, with the ability to differentiate into different cell types of their tissue or origin. Brahm pointed out, though, that despite the pluripotency of embryonic stem cells, they have yet to produce a single cure. Adult stem cells, on the other hand, have produced 72 cures and counting, according to Brahm. He cited various studies conducted across the world, everywhere from the United States to South Korea, in which spinal cord injuries, autoimmune disorders, Parkinson’s disease, multiple sclerosis, leukemia, arthritis and blindness, among many other diseases and injuries, have all been been treated by adult stem cell research. “There are 15 U.S. biotech companies solely devoted to developing cures using stem cells,” said Brahm, quoting from an article that appeared in a 2001 issue of Forbes Magazine. “But only two are focused on embryonic stem cell research. These companies don’t want to invest money in research that hasn’t produced any cures.” He said there are three hurdles embryonic stem cell research continues to face: immune-system complications, tumors — they have occurred 50 percent of the time in mouse stem cell experiments, according to Brahm — and the inability of scientists to rein in the power of embryonic stem cells. When embryonic stem cells have been implanted in humans, the results have been disastrous, Brahm said. According to an article in Neurology, Brahm said, a man in China had embryonic stem cells transplanted into his brain to cure Parkinson’s, and while some of the stem cells became brain cells like they were supposed to, the others became hair and bone cells. The man died a painful death as the bone tissue grew into his brain and killed him. “Embryonic stem cell research is still delayed by the rejection issue,” Brahm said. “It’s almost as if God has cursed embryonic stem cell research and blessed adult stem cell research.” Despite the failure of embryonic research to develop any cures for debilitating diseases and injuries, Brahm admitted that, one day, it could prove successful in treatments. “I’m not saying that they won’t ever gain the technology to find cures with embryonic stem cell research,” Brahm said. “It just hasn’t happened yet, and the best educated guesses are that it will be at least another 10 years before we’re closer to that point.” Even if embryonic stem cell research does eventually provide cures, Brahm feels it still should not be permissible. “Embryonic stem cell research kills a human being every single time,” Brahm said. “Would any research to find any cure be justified in killing its donors? Absolutely not.” Brahm blames the liberal media for doing a poor job of differentiating between the two types of stem cell research. “Nearly every major magazine has published polls on stem cell research,” Brahm said. “Almost every time you see a strong majority in favor of embryonic stem cell research. The problem is, they’re asking the wrong question. Instead of asking, ‘Do you think we should support research that could cure diabetes,’ we should be asking, ‘Do you support your tax dollars being used for medical research that would kill early human embryos.’” According to a poll of 1,000 adults nationwide conducted by the Polling Company, Inc./Women Trend in April 2006, 61 percent of those polled would vote for a candidate who supports stem cell research. Brahm pointed out that when the question was changed to “Would you vote for a candidate who supports stem cell research that includes research that would kill a human embryo or a candidate who supports stem cell research but opposes the kind that would kill a human embryo,” 60 percent were in favor of the candidate who supports stem cell research that does not involve the destruction of a human embryo. Brahm encourages those who are opposed to embryonic stem cell research to take action: pray for an end to embryonic stem cell research; educate others; contact your legislators; write letters to the editor; and give speeches on stem cell research at school, church, etc. “Although it is noble to desire to end human pain and suffering, cures must not come at the expense of ethics or morality,” Brahm said. “We must be ever vigilant to ensure that all life, from embryos to the elderly, and everyone in between, is respected, honored and protected.” login to post comments |